MYC and Miyoshi myopathy: Importantly, miR-22 overexpression restored lenalidomide sensitivity in OPM2LenRes by inducing MYC downregulation, further suggesting that this strategy represents a promising approach to restore IMiD sensitivity in MM refractory/relapsed patients (Figure 6d).